Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ingenol Mebutate after Cryotherapy for Hypertrophic AK
NCT02251652Phase 4Completed
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Apr 2013
- Primary completion
- Dec 2014
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ingenol mebutate in actinic keratosis (AK), sponsored by Icahn School of Medicine at Mount Sinai. Started Apr 2013; status: completed.
02
Drugs
ingenol mebutate
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT02251652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02251652.